Evidence map›Paper›PMID 27672313›Full record

ArticlePatient preference and adherence2016

Comparison of pharmacist and public views and experiences of community pharmacy medicines-related services in England.

Ruth M Rodgers, Shivaun M Gammie, Ruey Leng Loo, Sarah A Corlett, Janet Krska

Open access · goldAbstract read
In one paragraph

Article in Patient preference and adherence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pharmacy-based management for depression in adults.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2018
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Factors impacting job satisfaction among pharmacists in the Arab world: A qualitative study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  14. Article
  15. Article
  16. Public Perception of Pharmacists in Poland.International journal of environmental research and public health · 2022
    Article
  17. Challenges for Polish Community Pharmacists in Provision of Services to Immigrants and Non-Polish-Speakers in 2018.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ruth M RodgersMedway School of Pharmacy, The Universities of Greenwich and Kent, Chatham Maritime, UK.
Shivaun M GammieMedway School of Pharmacy, The Universities of Greenwich and Kent, Chatham Maritime, UK.
Ruey Leng LooMedway School of Pharmacy, The Universities of Greenwich and Kent, Chatham Maritime, UK.
Sarah A CorlettMedway School of Pharmacy, The Universities of Greenwich and Kent, Chatham Maritime, UK.
Janet KrskaMedway School of Pharmacy, The Universities of Greenwich and Kent, Chatham Maritime, UK.
Medway School of Pharmacy · GB

Funding

Medical Research Council G1002151
6 · The paper itself

Abstract

backgroundServices provided by community pharmacists designed to support people using medicines are increasing. In England, two national services exist: Medicine Use Reviews (MUR) and New Medicines Service (NMS). Very few studies have been conducted seeking views of the public, rather than service users, on willingness to use these services or expectations of these services, or determined whether views align with pharmacist perceptions.

objectiveTo compare the perceptions of pharmacists and the general public on medicines-related services, particularly MUR and NMS services.

methodsTwo parallel surveys were conducted in one area of England: one involved the general public and was administered using a street survey, and the other was a postal survey of community pharmacists. Similar questionnaires were used, seeking views of services, awareness, reasons for using services, and perceived benefits.

resultsResponse rates were 47.2% (1,000/2,012 approached) for the public and 40.8% (341/836) for pharmacists. Few people had experienced a discussion in a private consultation room or were aware of the two formal services, although their willingness to use them was high. Pharmacists estimated time spent on service provision as 10 minutes for MUR and 12 minutes for NMS, which aligned with acceptability to both pharmacists and the public. Pharmacists underestimated the willingness of the public to wait for an informal discussion or to make appointments for formal services. Both pharmacists and the public had high expectations that services would be beneficial in terms of increasing knowledge and understanding, but public expectations and experiences of services helping to sort out problems fell well below pharmacists' perceptions. People who had experienced a pharmacy service had different perceptions of pharmacists.

conclusionViews differed regarding why people use services and key aspects of service delivery. For services to improve, the pharmacy profession needs a better awareness of what the public, especially those with potential to benefit from services, view as acceptable and desirable.

Indexed as

community pharmacymedicines-related servicespharmacist perceptionspublic opinion

Identifiers

PMID27672313
PMCPMC5026175
OpenAlexW2516829366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.